Society for Immunotherapy of Cancer (SITC) – Genmab Cancer Immunotherapy in Hematologic Malignancies: DLBCL, FL, and CLL Translational Fellowship – Competitive LOI

Supports early career researches with a vested interest in furthering cancer immunotherapy research and translational immunotherapeutic approaches for the treatment of DLBCL, FL, and CLL.

Please note: for applicants prior to obtaining a tenure track faculty position, no more than four years from completing  postdoctoral training. Mentoring required.

Funding: $100K for 1 year

https://sitcancer.org/professional-development/fellowships/fellowships-2025/